CHECK-POINT INHIBITORS: WHAT ARE THEY USED FOR, ABOUT SIDE-EFFECTS AND PREDICTION OF EFFICACY

被引：0
|
作者：
Kapiteijn, E. [1 ]
机构：
[1] LUMC, Med Oncol, Leiden, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.7786
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SP0097
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [1] Treatment-related side effects as predictors of efficacy of check-point inhibitors (CPIs)
    Prince, Rebecca M.
    Daez, Laura
    Alcaraz-Sanabria, Ana
    Ethier, Josee-Lyne
    Ocana, Alberto
    Seruga, Bostjan
    Templeton, Arnoud J.
    Amir, Eitan
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] CHECK-POINT INHIBITORS AND THEIR KIDNEY INVOLVEMENT
    Villagrasa, Tania
    Luis Garcia, Jose
    Jimenez Mendoza, Sonia Cleofe
    Lado Fuentes, Mario
    Livianos Arias-Camison, Paloma
    Giovanna Dangelo, Maria
    Munar Vila, Maria Antonia
    Azkarate, Aitor
    Boyeras, Barbara
    Gomez Marques, Gonzalo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 : 251 - 251
  • [3] Renal damage secondary to check-point inhibitors
    Moliz, Candela
    Cavero, Teresa
    Morales, Enrique
    Gutierrez, Eduardo
    Alonso, Marina
    Praga, Manuel
    NEFROLOGIA, 2020, 40 (02): : 206 - 208
  • [4] Cholangiocarcinoma: Era of Immune Check-Point Inhibitors
    El Hag, Mohamed I.
    Wood-Trageser, Michelle
    Patel, Krishna
    Specht, Susan
    Sasatomi, Eizaburo
    Sun, Weijing
    Demetris, Anthony
    MODERN PATHOLOGY, 2018, 31 : 633 - 633
  • [5] CNS Inflammatory Complications of Check-Point Inhibitors
    Schindler, M.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (1_SUPPL) : 13 - 13
  • [6] Cholangiocarcinoma: Era of Immune Check-Point Inhibitors
    El Hag, Mohamed I.
    Wood-Trageser, Michelle
    Patel, Krishna
    Specht, Susan
    Sasatomi, Eizaburo
    Sun, Weijing
    Demetris, Anthony
    LABORATORY INVESTIGATION, 2018, 98 : 633 - 633
  • [7] Intracerebral Efficacy of Immune Check-Point Inhibitors in NSCLC Patients with Brain Metastases
    Ohyanagi, F.
    Shiihara, J.
    Kudo, F.
    Mizushina, Y.
    Ota, H.
    Koyama, S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S897 - S897
  • [8] The need for renal biopsy in oncology patients on check-point inhibitors check-point inhibitors: New triggers for extracapillary glomerulonephritis extracapillary glomerulonephritis
    Sanchez de la Nieta Garcia, M. Dolores
    del Pozo, Almudena Juez
    Cortes Toro, Jose Antonio
    Rodriguez Moreno, Antolina
    Garcia Carro, Clara
    Ruiz Ferreras, Elena
    Sanchez Fructuoso, Ana Isabel
    NEFROLOGIA, 2023, 43 : 107 - 109
  • [9] POTENTIATING THE EFFICACY OF IMMUNE CHECK-POINT INHIBITORS IN GLIOBLASTOMA BY INHIBITION OF CXCL12
    Makranz, Chen Cam-El
    Huguely, Caitlin
    Haynes, Tuesday
    Briceno, Nicole
    Zhang, Meili
    Davis, Dionne
    Song, Hua
    Zhang, Wei
    Gilbert, Mark
    Watanabe, Masashi
    NEURO-ONCOLOGY, 2024, 26
  • [10] Efficacy of immune check-point inhibitors (ICPi) in large cell neuroendocrine tumors of lung (LCNEC)
    Sherman, Shira
    Rotem, Ofer
    Shochat, Tzippy
    Zer, Alona
    Moore, Assaf
    Dudnik, Elizabeth
    LUNG CANCER, 2020, 143 : 40 - 46
12345